Disease Info Card

Thalassemia Intermedia

Information about Thalassemia Intermedia: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Thalassemia Intermedia

Most recent studies have shown that Thalassemia Intermedia shares some biological mechanisms with alpha-thalassemia, anemia, anemia-hemolytic, anemia-sickle-cell, beta-thalassemia, beta-thalassemia-intermedia, compression-of-spinal-cord, cooleys-anemia, extramedullary-hematopoiesis-(disorder), heart-failure, hemochromatosis, hemoglobinopathies, hemolysis-(disorder), hypertensive-disease, iron-overload, pulmonary-hypertension, thalassemia, thalassemia-trait, thrombophilia, thrombosis.

Among the many pathways, these few ones have gauged particular interests from scientists studying Thalassemia Intermedia, and have been seen in publications frequently: Aging, B Cell Activation, Cell Activation, Coagulation, Dna Amplification, Endothelial Cell Proliferation, Excretion, Fibrinolysis, Hemopoiesis, Immune Response, Localization, Pathogenesis, Platelet Activation, Protein Phosphorylation, Proteolysis, Response To Hydroxyurea, Secretion, Spermatogenesis, Translation, Virulence

Quite a number of genes have been found to play important roles in Thalassemia Intermedia, such as ATP6V0A2, EPO, EPX, FAM49B, GPHA2, HBA1, HBB, HBG1, HBG2, PMCH, SGCA, TF, TIMP1. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.